Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
5.53
+0.44 (8.64%)
At close: Feb 6, 2026, 4:00 PM EST
5.53
0.00 (0.00%)
After-hours: Feb 6, 2026, 4:00 PM EST
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $332.7 million as of February 6, 2026. Its market cap has increased by 11.09% in one year.
Market Cap
332.70M
Enterprise Value
255.50M
1-Year Change
11.09%
Ranking
Category
Stock Price
$5.53
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $332.70M, an increase of 794.36%. That is a compound annual growth rate of 20.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 306.20M | -1.73% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
| May 2, 2014 | 37.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 356.87M |
| Immix Biopharma | 356.22M |
| Puma Biotechnology | 346.69M |
| Aura Biosciences | 346.09M |
| Rocket Pharmaceuticals | 345.23M |
| Foghorn Therapeutics | 328.64M |
| Candel Therapeutics | 325.00M |
| Atea Pharmaceuticals | 324.23M |